Crossref


2. Hepatic fat infiltration and clinical indicators in polycystic ovary syndrome: insights from MRI HISTO sequences

- Min Ling

- Shuting Lu

- Runrong Chen

- Jiangnian Gong

- Bin Tian

- Yingfen Qin

- Jia Zhou

- Zisan Zeng

3. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial

- Signe Frøssing

- Malin Nylander

- Elizaveta Chabanova

- Jan Frystyk

- Jens J. Holst

- Caroline Kistorp

- Sven O. Skouby

- Jens Faber

4. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease

- Nicolás Salva-Pastor

- Norberto C. Chávez-Tapia

- Misael Uribe

- Natalia Nuño-Lámbarri

7. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

- Mary E. Rinella

- Brent A. Neuschwander-Tetri

- Mohammad Shadab Siddiqui

- Manal F. Abdelmalek

- Stephen Caldwell

- Diana Barb

- David E. Kleiner

- Rohit Loomba

9. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones

- Sara Arefhosseini

- Mehrangiz Ebrahimi-Mameghani

- Farzad Najafipour

- Helda Tutunchi

10. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database

- Balachandran Kumarendran

- Michael W. O’Reilly

- Konstantinos N. Manolopoulos

- Konstantinos A. Toulis

- Krishna M. Gokhale

- Alice J. Sitch

- Chandrika N. Wijeyaratne

- Arri Coomarasamy

- Wiebke Arlt

- Krishnarajah Nirantharakumar

- Jenny E Myers

11. Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS

- Salvatore Petta

- Alessandro Ciresi

- Jessica Bianco

- Vincenzo Geraci

- Roberta Boemi

- Luigi Galvano

- Franco Magliozzo

- Giovanni Merlino

- Antonio Craxì

- Carla Giordano

- Andrew Wolfe

12. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025

- E. Roeb

- A. Canbay

- H. Bantel

- J. Bojunga

- J. de Laffolie

- M. Demir

- U. W. Denzer

- A. Geier

- W. P. Hofmann

- C. Hudert

- T. Karlas

- M. Krawczyk

- T. Longerich

- T. Luedde

- M. Roden

- J. Schattenberg

- M. Sterneck

- A. Tannapfel

- P. Lorenz

- F. Tacke

14. Nonalcoholic fatty liver disease shows significant sex dimorphism

- Xing-Yu Chen

- Cong Wang

- Yi-Zhou Huang

- Li-Li Zhang

15. Metabolic Syndrome in Polycystic Ovary Syndrome

- Yun-Chiao Hsieh

- Po-Kai Yang

- Mei-Jou Chen

17. Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome

- Mohammad Maysara Asfari

- Muhammad Talal Sarmini

- Firas Baidoun

- Yasser Al-Khadra

- Yamen Ezaizi

- Srinivasan Dasarathy

- Arthur McCullough

21. Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications

- Ana-Maria Singeap

- Carol Stanciu

- Laura Huiban

- Cristina Maria Muzica

- Tudor Cuciureanu

- Irina Girleanu

- Stefan Chiriac

- Sebastian Zenovia

- Robert Nastasa

- Catalin Sfarti

- Camelia Cojocariu

- Anca Trifan

- Branka Filipović

25. Polycystic ovary syndrome: approach to correction of metabolic disorders

- Л. В. Калугіна

- Т. Ф. Татарчук

28. GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity

- Ozlem Celik

- Dilek Yazici

- Andreea Ciudin

- Djuro Macut

- Dragan Micic

- Volkan Yumuk

- Bulent Okan Yildiz

29. Polycystic Ovary Syndrome and Medical Conditions

- NANETTE L. ROLLENE

- JESSICA A. LENTSCHER

- ASHLEIGH M. HEMPHILL

- ALAN H. DECHERNEY

31. NAFLD Associated Comorbidity

- L. B. Lazebnik

- S. V. Turkina

32. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome

- Stavroula A. Paschou

- Stergios A. Polyzos

- Panagiotis Anagnostis

- Dimitrios G. Goulis

- Christina Kanaka-Gantenbein

- Irene Lambrinoudaki

- Neoklis A. Georgopoulos

- Andromachi Vryonidou

34. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction

- Vincenza Di Stasi

- Elisa Maseroli

- Giulia Rastrelli

- Irene Scavello

- Sarah Cipriani

- Tommaso Todisco

- Sara Marchiani

- Flavia Sorbi

- Massimiliano Fambrini

- Felice Petraglia

- Mario Maggi

- Linda Vignozzi

36. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis

- A. L. L. Rocha

- L. C. Faria

- T. C. M. Guimarães

- G. V. Moreira

- A. L. Cândido

- C. A. Couto

- F. M. Reis

37. Obesity and polycystic ovary syndrome

- Thomas M. Barber

- Stephen Franks

38. Clinico-Metabolic Profile in Lean Versus Obese Polycystic Ovarian Syndrome Women

- Nidhi Makhija

- Surekha Tayade

- Shikha Toshniwal

- Hard Tilva

43. Endocrinology update

- Christopher Redford

- Antonia Brooke

44. Non-alcoholic fatty liver disease in polycystic ovarian syndrome in Indian women

- Sujata Siwatch

- Virendra Singh

- Lakhbir K. Dhaliwal

- Sunita Kumari

- Kartar Singh

45. NAFLD: comorbidity and associated diseases

- M. A. Livzan

- O. V. Gaus

- N. A. Nikolaev

- T. S. Krolevetz

49. An integrated multidisciplinary model of care for addressing comorbidities beyond reproductive health among women with polycystic ovary syndrome in India

- Anushree Devashish Patil

- Rama Ashok Vaidya

- Shahina Begum

- Sanjay L. Chauhan

- Srabani Mukherjee

- Pratibha P. Kokate

- Beena Nitin Joshi

52. Therapeutic pipeline in nonalcoholic steatohepatitis

- Raj Vuppalanchi

- Mazen Noureddin

- Naim Alkhouri

- Arun J. Sanyal

55. Using machine learning to predict patients with polycystic ovary disease in Chinese women

- Chen-Yu Wang

- Dee Pei

- Chun-Kai Wang

- Jyun-Cheng Ke

- Siou-Ting Lee

- Ta-Wei Chu

- Yao-Jen Liang

56. Non‐alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta‐analysis

- Mohamed Shengir

- Tianyan Chen

- Elena Guadagno

- Agnihotram V Ramanakumar

- Peter Ghali

- Marc Deschenes

- Philip Wong

- Srinivasan Krishnamurthy

- Giada Sebastiani

58. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis

- Aikaterini Lavrentaki

- Tom Thomas

- Anuradhaa Subramanian

- George Valsamakis

- Neil Thomas

- Konstantinos A. Toulis

- Jingya Wang

- Barbara Daly

- Ponnusamy Saravanan

- Dana Sumilo

- George Mastorakos

- Abd A. Tahrani

- Krishnarajah Nirantharakumar

59. Electroacupuncture Versus Aerobic Interval Training on Liver Functions in Patients with Nonalcoholic Fatty Liver

- Ramy Salama Draz

- Zahra M.H. Serry

- Awny Fouad Rahmy

- Maha saber El Bardesi

- Mona Mohamed Taha

60. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non‐obese non‐alcoholic fatty liver disease

- J. J. Kim

- D. Kim

- J. Y. Yim

- J. H. Kang

- K. H. Han

- S. M. Kim

- K. R. Hwang

- S. Y. Ku

- C. S. Suh

- S. H. Kim

- Y. M. Choi

64. Female infertility, infertility-associated diagnoses, and comorbidities: a review

- Brent Hanson

- Erica Johnstone

- Jessie Dorais

- Bob Silver

- C. Matthew Peterson

- James Hotaling